CSF3 and cancer: After binding of G-CSF to its receptor (G-CSFR), G-CSF/G-CSFR complex is internalized and degraded.26 In the context of cancer, tumor tissue constantly releases G-CSF; therefore, self-regulation of G-CSF concentration is not possible, resulting in aberrant neutrophil functionality.